Abbott Gains Synchrony Accommodating IOL Via $400 Mil. Visiogen Purchase

Abbott will strengthen its premium intraocular lens offerings and enter the accommodating IOL market for the first time through its $400 million purchase of Visiogen, announced Sept. 2